Gilead Sciences (GILD)

Cost of Revenue

$6.22B

TTM · Period ending: · USD

GILD logo

GILD Cost of Revenue

Latest reported$6.22B
GILD TTM Cost of Revenue ($0.00 → $6.22B)
High-resolution chart · PNG

GILD cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gilead Sciences Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
6,217,000,000
6,139,000,000
6,234,000,000
6,191,000,000
6,196,000,000
6,239,000,000
6,251,000,000
6,760,000,000
6,751,000,000
6,649,000,000
6,498,000,000
5,804,000,000
5,634,000,000
5,634,000,000
5,657,000,000
6,888,000,000
6,716,000,000
6,664,000,000
6,601,000,000
5,372,000,000
5,290,000,000
4,964,000,000
4,572,000,000
4,857,000,000
4,751,000,000
4,687,000,000
4,675,000,000
4,562,000,000
4,613,000,000
4,809,000,000
4,853,000,000
4,539,000,000
4,485,000,000
4,415,000,000
4,371,000,000
4,190,000,000
4,287,000,000
4,025,000,000
4,261,000,000
4,248,000,000
4,183,000,000
4,317,000,000
4,006,000,000
4,006,780,000
3,929,780,000
3,856,780,000
3,787,780,000
3,582,523,000
3,277,391,000
3,037,054,000
2,858,502,000
2,676,797,000
2,592,198,000
2,524,880,000
2,471,363,000
2,379,992,000
2,314,712,000
2,231,230,000
2,124,410,000
2,036,300,000
1,981,895,000
1,903,557,000
1,869,876,000
1,846,938,000
1,779,054,000
1,706,574,000
1,595,558,000
1,443,690,000
1,334,173,000
1,216,812,000
1,127,246,000
1,021,257,000
919,534,000
836,981,000
768,771,000
708,518,000
619,849,000
514,601,000
433,320,000
352,175,000
307,882,000
293,268,000
260,326,000
234,886,000
210,230,000
189,053,000
166,587,000
151,160,000
136,254,000
126,268,000
112,691,000
98,966,000
93,442,000
79,054,000
69,724,000
63,350,000
52,146,000
45,225,000
43,764,000
34,763,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.